The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year

PHASE2CompletedINTERVENTIONAL
Enrollment

144

Participants

Timeline

Start Date

Not specified

Study Completion Date

October 31, 1998

Conditions
HIV Infections
Interventions
DRUG

Indinavir sulfate

DRUG

Saquinavir

Trial Locations (16)

10003

Beth Israel Med. Ctr. (Mt. Sinai), New York

10016

NY Univ. HIV/AIDS CRS, New York

14260

SUNY - Buffalo, Erie County Medical Ctr., Buffalo

14642

Univ. of Rochester ACTG CRS, Rochester

33136

Univ. of Miami AIDS CRS, Miami

43210

The Ohio State Univ. AIDS CRS, Columbus

60611

Northwestern University CRS, Chicago

60612

Rush Univ. Med. Ctr. ACTG CRS, Chicago

63110

Washington U CRS, St Louis

63112

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

80045

University of Colorado Hospital CRS, Aurora

90502

Harbor-UCLA Med. Ctr. CRS, Torrance

94110

Ucsf Aids Crs, San Francisco

94304

Stanford CRS, Palo Alto

98104

University of Washington AIDS CRS, Seattle

02114

Massachusetts General Hospital ACTG CRS, Boston

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000848 - The Anti-HIV Effects of Saquinavir Soft Gelatin Capsules Versus Indinavir in Patients Who Have Used Saquinavir Hard Gelatin Capsules for One Year | Biotech Hunter | Biotech Hunter